Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Genomic approaches in acute leukemia.

Kimberly Stegmaier¹

¹Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. kimberly_stegmaier@dfci.harvard.edu

Best Practice & Research. Clinical Haematology

|March 7, 2006

Summary

Expression-based genomic tools aid medical research, especially for blood cancers. DNA microarrays refine disease classification, predict patient outcomes, and identify new therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

Cancer discovery·2026

Same author

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Science translational medicine·2026

Same author

USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

Blood·2026

Same author

A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity.

Nature cancer·2026

Same author

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Blood·2026

Area of Science:

Genomics
Medical research
Hematologic malignancy

Background:

Expression-based genomic approaches are increasingly vital in medical research.
Hematologic malignancies present complex challenges for diagnosis and treatment.

Purpose of the Study:

To trace the application of expression-based genomic approaches in medical research.
To discuss the role of DNA microarray technology in hematologic malignancy research.
To explore signature-based screening for therapeutic target identification.

Main Methods:

Review of expression-based genomic approaches.
Discussion of DNA microarray technology.
Exploration of signature-based screening methods.

Main Results:

DNA microarray technology aids in refining disease taxonomy.
Genomic approaches contribute to developing outcome prediction models.
Signature-based screening identifies therapeutic targets without prior knowledge.

Conclusions:

Expression-based genomics, particularly DNA microarrays, significantly advances hematologic malignancy research.
These approaches refine disease classification, improve outcome prediction, and identify novel therapeutic strategies.
Signature-based screening offers a powerful method for discovering therapeutic targets.

Related Experiment Videos